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INTRODUCTION ATP-binding cassette (ABC) proteins constitute one of the largest protein families found in all kingdoms of life. In humans 48 genes encode for ABC proteins. Most of them are transporters and expressed in tissue-specific manner to serve translocation of diverse cargo across cellular membranes. Malfunction of 22 ABC proteins has been reported to be linked to at least 27 disease etiologies . A functional ABC transporter is composed of a minimum of four domains: two transmembrane domains (TMDs) and two nucleotide binding domains (NBDs) . The former confer substrate specificity and provide the translocation paths for ligands, while the latter are involved in binding and hydrolyzing ATP, thus providing energy for the active transport of cargo molecules. Throughout the ABC family NBDs contain conserved motifs, including the Walker A and B motifs, ABC signature sequence and A-, D-, H-and Q-loops, which are unique to the protein family (Higgins, 1992; Hyde et al., 1990; Walker et al., 1982) . These conserved motifs form composite nucleotide binding sites (NBSs). These sites involve the Walker A and B motifs, Q-and H-loop of one, and the signature motif and D-loop of the other NBD (Jin et al., 2012) .
The bile salt export pump (BSEP/ABCB11) functions at the canicular membrane of hepatocytes and is responsible for the concentrative transport of bile salts from the hepatocyte cytoplasm into the bile canaliculus. Malfunction of this transporter leads to different disease entities: (i) progressive familial intrahepatic cholestasis type 2 (PFIC2), (ii) benign recurrent intrahepatic cholestasis (BRIC) and (iii) cholestasis of pregnancy (Kubitz et al., 2012; Stieger et al., 2007) . Furthermore, several systemically administered drugs, among them antidiabetics, antibiotics, endothelin antagonists, and tyrosine kinase inhibitors compromise BSEP function and thus have the undesired drug side effect of causing intrahepatic cholestasis (Dawson et al., 2012; Montanari et al., 2016; Morgan et al., 2010; Pedersen et al., 2013; Ritschel et al., 2014) .
BSEP is one of four full length transporters of the ABCB subfamily. Available crystal structures of type I exporters indicate twofold (C2) rotational symmetry (Aller et al., 2009 ; MOL #108688 Dawson and Locher, 2006; Shintre et al., 2013) . In homodimeric half transporters such as ABCB10, binding of ATP at the NBD interface occurs in two rotationally symmetric and otherwise identical NBSs. Similarly, protein architecture necessitates two rotationally symmetric substrate binding modes at the TMD interface. In full transporters (commonly appreciated to have arisen from half transporters by gene duplication) (Chen et al., 1986 ) the two halves have diverged in the course of evolution, but nevertheless have retained similarity. Our group previously demonstrated that the paradigmatic ABCB transporter P-gp (ABCB1) can bind substrates such as rhodamine 123, verapamil, vinblastine and propafenones in dual pseudo symmetric mode (Donmez Cakil et al., 2014; Parveen et al., 2011; Spork et al., 2017) . As P-gp has two canonical nucleotide binding sites, the possibility exists that substrate binding modes and nucleotide binding sites function in dedicated manner. In contrast to P-gp, BSEP has only one hydrolysis competent nucleotide binding site (NBS2), which likely drives taurocholate transport from a single binding site.
We followed the strategy to generate mutants, in which based on conservation within the ABCB subfamily, non-canonical residues were replaced by canonical ones. We subsequently explored the effect of these mutations on taurocholate (TC) transport and ATPase activity. Our data show that selected residues in the non-canonical NBS1 of BSEP are crucial for function, as both transport and ATPase activity decreased, when these residues were replaced. We also mutated conserved lysines of the Walker A motifs and conserved aspartates of the D-loops in both NBS1 and NBS2. Furthermore, we exchanged the catalytic glutamate between NBS2 and NBS1. Most interestingly, our experiments showed that the ensuing mutant M584E/E1244Q retained the ability to transport taurocholate. However, active transport characteristics were lost in this mutant and with the help of a kinetic model we were able to demonstrate that it functions as an ATP-gated facilitator. These experiments allowed us to shed light on the transport mechanism and develop a model for inter-domain communication. Louis, MO, USA), and Filter Count was purchased from PerkinElmer (Waltham, MA, USA).

MATERIALS AND METHODS
Materials
Sodium taurocholate, Mg(NO 3 ) 2 , DNase I, ATP, cell culture medium and supplements were bought from Sigma (St. Louis, MO, USA). The protease inhibitor cocktail (PIC) was from Roche (Mannheim, Germany). Chemicals used for buffer preparation including sucrose, KCl and KNO 3 , HEPES and TRIS were purchased from Roth (Karlsruhe, Germany).
Generation of BSEP mutants
The following mutations were introduced into human BSEP in the entry vector pENTR4 (Invitrogen, Carlsbad, USA) by using the listed forward and reverse primers (Microsynth, Wolfurt, Austria). The BSEP gene was subsequently transferred from pENTR4 to the proprietary pCEP4d destination vector by using the gateway cloning technology, as described (Hartley et al., 2000) . Authenticity of all mutants was confirmed by sequencing of the entire insert in the destination vector. Also the destination vector was sequenced in its entirety prior to transfer of the insert. C in an atmosphere containing 5% CO 2 . After 24 hours, a mixture of 5 µg BSEP containing pCEP4d plasmid and 10 µl TurboFect in 500 µl of DMEM was added to each flask for transfection. Cells were subsequently incubated for another 48 hours, before they were transferred to a T75 flask in selection medium (DMEM, 10% FBS and 85 µg/ml of hygromycin B). After 3-5 days cells were transferred to T175 flask and used for experiments after another 3-5 days.
Membrane vesicle preparation
Plasma membrane vesicles were isolated according to Hirano et al., (Hirano et al., 2005) and Müller et al., (Muller et al., 1994) . 8-10 days after transfection, cells were harvested, resuspended in 1 ml of ice-cold PBS containing protease inhibitor cocktail (PIC) and centrifuged at 500xg for 6 minutes at 4°C. The cell pellet was washed with ice-cold PBS containing PIC, and again centrifuged at 500xg for 10 minutes at 4°C. The pellet was diluted 40-fold with hypotonic buffer (1 mM Tris/HCl, 0.1 mM EDTA, pH 7.4) containing PIC and 100U of DNase I (dissolved in 1 ml 20 mM Tris, 50 mM NaCl) and stirred gently (~150rpm)
for 1 hour at 4°C. Samples were centrifuged at 141,000xg (30 min, 4°C) and the pellet was resuspended in 4 ml of ice-cold isotonic TS buffer (10 mM Tris/HCl, 250 mM sucrose, pH 7.4) without PIC. The resuspended pellet was homogenized by 30 strokes with a Dounce B homogenizer (glass/glass, tight pestle). The homogenate was layered over a 38% (w/vol) sucrose solution in 5 mM Tris/Hepes (pH 7.4) and tubes were centrifuged in an SW28 rotor (L60 ultracentrifuge) at 141,000xg for 2 hours at 4°C. The plasma membrane fraction was collected at the gradient interface, diluted to 9 ml with TS buffer, and centrifuged in a fixed angled TLA 100.3 rotor at 100,000xg for 30 minutes at 4°C. The pellet was resuspended in
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The membrane vesicles were frozen in liquid nitrogen and stored at -80°C until use. The protein concentration was determined using the Bradford assay with bovine serum albumin as the standard.
Western blot analysis
Membrane proteins (2.5 µg/ lane) were separated in a 7.5% sodium dodecyl sulphate polyacrylamide gel and transferred onto a 0.45 µm nitrocellulose membrane (GE Healthcare Life Sciences, Buckinghamshire, UK). The nitrocellulose membrane was incubated overnight at 4°C with a mouse monoclonal anti-BSEP antibody (1:1000 dilution, BSEP (F-6), Santa
Cruz Biotechnology Inc, Texas, USA) and a mouse monoclonal anti-Na + /K + ATPase antibody
(1:1000 dilution, M7-PB-E9 Santa Cruz Biotechnology Inc, Texas, USA). Then, the nitrocellulose membrane was further incubated for one hour at room temperature with an anti-mouse secondary antibody, conjugated to horse-radish peroxidase (1:500 GE Healthcare Life Sciences, UK). The protein-antibody complex was detected by using SuperSignal West Pico Chemiluminescence Substrate (Thermo Fischer Scientific, Vienna, Austria) according to the manufacturer's recommendations.
Vesicle Transport Studies
ATP-dependent uptake of taurocholate into isolated plasma membrane vesicles was measured using a rapid filtration technique as described previously (Gerloff et al., 1998) .
Vesicles were diluted with resuspension buffer (50 mM sucrose, 100 mM KNO 3 , 10 mM Tris/Hepes pH 7.4) to obtain a concentration of 2.5 mg/ml. 10µl of vesicles were prewarmed in a 37°C water bath for 30 seconds. Thereafter, taurocholate uptake was initiated by the addition of 40 µl uptake buffer (50 mM sucrose, 100 mM KNO 3 , 12. (Bathena et al., 2013) . At these concentrations we thus did not expect damage to occur in our assay system. (ii) The concentration of bile acids in wild-type vesicles was found to be about 4 fold higher than in the incubation medium and thus would not exceed 10µM. (iii) in the original publication by Gerloff et al., (Gerloff et al., 1998) This indicates that vesicle stability is not compromised at the taurocholate concentrations used in our assay system. The reaction was monitored over time intervals that assured linearity of the reaction at a taurocholate concentration of 2.5µM. Transport was stopped by adding 3 ml of ice-cold stop solution (50 mM sucrose, 100 mM KCl, 10 mM Tris/HCl, pH 7.4) into the incubation tube and immediately filtering the mixture through a 0.45 µm nitrocellulose acetate filter (Sartorius, Göttingen, Germany), which had been pre-treated by passing 3 ml of a 1 mM taurocholate solution through the filter. The tube was then rinsed with an additional 3 ml of ice-cold stop solution, which was then also filtered. Filters were washed 2 times with 3 ml of ice-cold stop solution and immersed and dissolved in liquid scintillation fluid (Filter Count, PerkinElmer
Inc.). Vesicle associated radioactivity was measured in a Packard CA2000 liquid scintillation counter (Packard International Inc. TX, USA). In order to control for non-specifically bound radioactivity, transport studies were performed in the presence and absence of 5 mM ATP.
To monitor taurocholate transport in the presence of ADP and AMP-PNP, ATP was replaced with these nucleotides in the uptake buffer at identical concentration.
Time dependence of taurocholate transport
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Osmolarity Plot
The osmolarity plot was prepared according to Wlcek et al., (Wlcek et al., 2014) .
Briefly, the membrane vesicles (25 µg) were incubated in uptake buffer (50 mM sucrose, 100 mM KNO 3 , 12.5 mM Mg(NO 3 ) 2 , 10 mM Tris/Hepes, pH 7.4) at 37°C for 10 minutes. Outside osmolarity was increased by adding sucrose (50 mM (isotonic) to 800 mM). Taurocholate transport (pmol/mg protein/min) was plotted against the inverse of the osmolarity. Nonspecific binding of taurocholate to vesicles was calculated by extrapolating the curve to the intercept with the y-axis.
ATPase assay
The ATPase activity was determined by measuring the release of inorganic phosphate (Pi) using a calorimetric method described by Chifflet et al., and Schmid et al., (Chifflet et al., 1988; Schmid et al., 1999) . Briefly, 25 µg of membrane vesicles were added to the ATPase assay buffer (300 mM sucrose, 4.8 mM MgCl 2 , 0.2 mM EGTA, 10 mM NaN 3 , 0.17 mM ouabain and 20 mM Tris/HCl, pH 7.4). Ouabain, EGTA and NaN 3 were added in the assay mixture to block Na + /K + , Ca 2+ and mitochondrial ATPases, respectively. Orthovanadate (0.56 mM) was used to block ABC-transporter associated ATPase activity. BSEP-associated
ATPase activity was calculated as the difference of total and vanadate-insensitive ATPase activity. The latter had to be corrected for vanadate-sensitive ATPase activity in mock transfected cells. For ATPase stimulation taurocholate was used at a concentration of 50 µM.
The assay mixture was prewarmed to 37°C for 5 minutes and the reaction was started by
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Homology modeling of BSEP D simulation:
The sequences of ABCB1, BSEP and Sav1866 were aligned and manually adjusted according to Stockner et al., (Stockner et al., 2009 ). Models of BSEP were created with MODELLER version 9.15 (Sali and Blundell, 1993) using the crystal structure of Sav1866
from Staphylococcus aureus as the template (PDB ID: 2ONJ (Dawson and Locher, 2007) ).
Mutations of residues in NBS1 were introduced with MODELLER. The extracellular loop 1 was modeled to continue α-helicity of transmembrane helices 1 and 2, based on secondary structure predictions. The co-crystallized nucleotide AMP-PNP was replaced by ATP, Na + ions in the crystal structure were replaced by Mg +2 ions.
Kinetic modeling
Taurocholate uptake and ATPase activity of BSEP-containing plasma membrane vesicles were simulated according to a previously published kinetic model of the ABCB1 transport cycle (Al-Shawi et al., 2003) with modifications. The geometry of the vesicles was assumed to be spherical with a diameter of 2 µm (V= 4.18 fl). Loss of taurocholate from vesicles to the incubation medium was taken into account in the model. Permeability of taurocholate was estimated on basis of the physicochemical property "polar surface area" as described (Schmid et al., 2015) . Time-dependent changes in state occupancies, as well as substrate efflux and phosphate generation were evaluated by numerical integration of the resulting This article has not been copyedited and formatted. The final version may differ from this version. system of differential equations using the Systems Biology Toolbox (Schmidt and Jirstrand, 2006) and MATLAB 2012a (Mathworks, Natick, MA, USA).
Statistical analysis
The GraphPad prism software (GraphPad Software, Inc., La Jolla, CA, USA) was used for data analysis. Statistically significant differences between basal and taurocholate stimulated ATPase activity was determined by two-way ANOVA followed by Bonferroni post hoc analysis. For comparison of taurocholate transport one-way ANOVA followed by Tukey's post hoc analysis was used. A p-value < 0.05 was considered to be statistically significant. A comparison of the goodness of fit for a linear and nonlinear fit was performed using the extra sum of squares F test. In order to be able to perform an extra sum-of squares F test, we alternatively fitted data points in Figure 10 not only with the kinetic model, but also with a quadratic function according to the equation y=ax2+bx+c.
RESULTS
Role of non-canonical residues in NBS1 for taurocholate transport and BSEP ATPase activity
Two ATP molecules are bound and sandwiched between the two NBDs of ABC proteins in two composite nucleotide binding sites (NBSs), NBS1 and NBS2. The two NBDs form direct contacts with each other by contribution of residues, which are listed in Table 1 and shown in a homology model of BSEP in Figure 1 . Contact residues are defined as those residues in one NBD, which can come in contact with residues in the other NBD. Some of these are also in with contact the ATP molecules. Figure 1 shows contact residues in surface rendering for NBD1 ( Figure 1A ) and NBD2 ( Figure 1B ) in a head on view onto the respective NBD and in a top view for both NBDs ( Figure 1C ). All contact residues lie close, or conform to conserved residues of NBD-motifs in the primary sequence. All four full transporters of the ABCB subfamily show complete contact-interface conservation, except for four residues in BSEP, which all lie in the non-canonical NBS1 (Figure 2 ).
This article has not been copyedited and formatted. The final version may differ from this version. In order to assess the role of these four amino acid residues and to establish the functional relevance of asymmetry in the NBSs, we mutated them to conform to those, which are found in other members of the ABCB subfamily (E502S/M584E/R1221G/E1223Q). In addition to the quadruple, we also created a single mutant, in which the methionine of the NBD1 Walker B motif was replaced by glutamate (M584E). Taurocholate (TC) transport activity was evaluated in inside-out membrane vesicles prepared from HEK293 cells expressing wild-type or mutant BSEP. Expression was determined by Western blotting and found to be similar in wild-type and mutants. A representative immunoblot is shown in Figure   3A . The column graph in Figure 3B gives results from repeat experiments and Figure 3C shows the corresponding transport data. The Walker B single mutant (M584E), in which hydrolysis competency was imparted to NBS1, showed approximately 90% of wild-type transport activity. In the quadruple mutant, in which the four deviant amino acid residues in NBS1 were replaced by canonical residues (as found in other ABCB subfamily members), transport was reduced to about 35% ( Figure 3C ).
As ATP binding and hydrolysis is a pre-requisite for transport function, we also measured basal and taurocholate stimulated ATPase activity of the mutants. Two negative controls were used in these experiments: (i) vesicles from mock transfected cells and (ii) cells transfected with the E1244Q mutant. This mutant lacks a catalytic glutamate and thus is unable to either hydrolyze ATP or transport taurocholate (see below). Vesicle preparations from these negative controls showed vanadate sensitive ATPase activity of around 3 nmol P i /mg/min. This ATPase activity is not BSEP associated as it is not stimulated by taurocholate (Figure 4 ). Exploring the role of canonical residues in NBS1 and NBS2
Despite the presence of individual non-canonical residues, most of the residues in NBS1 are conserved within the ABCB subfamily. These include the lysine residue in the Walker A motif and the aspartate residue in the D-loop. Hence, we explored the effect of mutation of these residues on taurocholate transport and ATPase activity in NBS1. As a control we also introduced these mutations in NBS2.
Role of Walker A lysine residues
Walker A lysines were shown to form contacts with the β and γ phosphate of ATP (Hung et al., 1998) . We replaced these lysines by methionines (K461M and K1119M), as previously described for ABCB1 (Barsony et al., 2016; Lapinski et al., 2001) . Surface expression of these mutants was found to be comparable to that of wild-type protein ( Figure   5A and B). Taurocholate transport was found to be abolished in both mutants ( Figure 5C ), while a basal BSEP-associated ATPase activity was still found to be associated with the mutants. The K1119M mutant lost its ability to be stimulated by taurocholate (Figure 4 ).
These results suggest that communication between the taurocholate binding site and NBS2
depends on the presence of this conserved lysine residue in NBS2.
Role of conserved D-loop aspartates
In an additional series of experiments we mutated D-loop aspartates in NBS1 and NBS2, because of their previously reported role in NBS-NBS communication (Hohl et al., 2014) . Surface expression was comparable to that of wild-type ( Figure 6A and B). Mutation of aspartate (D590) in canonical NBS2 to alanine decreased transport activity to the level observed in mock transfected cells. In contrast mutation of the analogous aspartate residue in NBS1 to alanine (D1250A) resulted in a reduction of transport activity to about 50% of wild-type. The double mutant D590A/D1250A was inactive ( Figure 6C ). Basal ATPase activity in the single and the double mutant was comparable to that of wild-type protein.
NBS1 mutant D1250A was stimulated by taurocholate. However, this stimulation was absent in the D590A (NBS2) and in the double mutant D590A/D1250A (Figure 4 ).
This article has not been copyedited and formatted. The final version may differ from this version. is not. We first mutated the catalytic glutamate of NBS2 to glutamine (E1244Q) to render it hydrolysis incompetent. Again, plasma membrane expression of this mutant was comparable to that of wild-type protein ( Figure 7A and B). This mutant was transport deficient as its transport activity was not significantly different from that found in mock transfected cells. Also
ATPase activity was comparable to that found in mock transfected cells (Figure 4 ). Thus any BSEP-associated ATPase activity was absent.
We next replaced the non-canonical methionine residue in NBS1 with glutamate in the background of the E1244Q mutant. The catalytic glutamate was thus exchanged between NBS2 and NBS1 (M584E/E1244Q) in order to reinstate hydrolysis competency in the protein. The mutant again showed a surface expression that was comparable to that of wild-type protein ( Figure 7A and B). Most interestingly, the double mutant consistently showed approximately 15% residual transport activity ( Figure 7C ), which was demonstrated to be BSEP mediated by using the high affinity inhibitor pioglitazone (published IC 50 values of 0.4µM (Morgan et al., 2010) and 0.3µM (Dawson et al., 2012) ). At a concentration of 10µM of pioglitazone, transport was completely abolished in the mutant and in wild-type ( Figure 7C ).
This residual transport activity by the M584E/E1244Q mutant was significantly higher than that of the catalytically inactive mutant E244Q and mock ( Figure 7D ). In order to further characterize this mutant, we monitored taurocholate transport in the absence of nucleotide and in presence of ATP, ADP and AMP-PNP. Similar to wild-type, the mutant showed strict ATP dependence of transport activity (Figure 8 ).
We, further, determined basal ATPase activity of the mutant and the ability of taurocholate to stimulate it (Figure 4 ). Basal activity was comparable to wild-type, indicating that the M584E/E1244Q mutant was capable of hydrolysing ATP. As NBS2 in this mutant is This article has not been copyedited and formatted. The final version may differ from this version. Taurocholate is an amphipathic small molecule, which readily distributes into the environment of biomembranes. In order to discriminate between biomembrane partitioning and accumulation in the vesicle lumen, transport was monitored in the presence of an increasing concentration of sucrose in the uptake buffer. This collapses vesicles (supplemental Figure S2 ). Transport rate is expected to be linearly related to the inverse of the osmolarity, where the intercept with the ordinate conforms to vesicle-associated radioactivity at zero inside volume. Under the assumption that binding of taurocholate to the transporter does not significantly contribute to this value, the intercept of wild-type and mutant should be identical. Figure 10 shows that the mutant indeed demonstrates linear behaviour. In contrast, data points for wild-type transporter seem to deviate from linearity. When fitted linearly, the intercept value is much higher than for the mutant. A similar deviation of data points from linear fits can be observed in an experimental set up that is comparable to ours (Wlcek et al., 2014) . In order to resolve the discrepancy of nonconforming y-intercepts for wild-type protein This resets the transporter to the inward facing conformation. The second molecule of ATP can also bind in the absence of substrate and has to undergo hydrolysis in order to return the transporter to a substrate-binding competent state. This empty cycle satisfies the observation that basal ATPase activity is observed in the absence of taurocholate.
Because of the fact that removal of ATP and substrate from the medium led to progressive loss of previously accumulated taurocholate from the vesicles, we also allowed for a concentration-gradient driven loss across the vesicle membrane. As laid out in the methods section, this loss of taurocholate into the vesicle environment is not due to detergent action of the substrate. Estimates for diffusion rates were obtained experimentally by diluting wild-type vesicles 60-fold at steady state (data not shown). We also devised a model for a facilitator (supplemental Figure S 3B ). Here again one ATP is bound to the transporter, but this time to NBS2 rather than to NBS1. Binding of a second molecule of ATP generates the outward facing conformation. In the presence of substrate the quaternary complex ATP 2 -T e -S is thus shared by wild-type protein and mutant. Substrate dissociates at lower rate than in wild-type, in which this process is promoted by ATP hydrolysis in NBS2.
The ATP molecule in NBS2 can now leave the transporter without being hydrolyzed, but only when hydrolysis in NBS1 takes place. The following evidence supports this notion: (i) transport is abolished when the protein is rendered hydrolysis incompetent (mutation of E1244 to glutamine) and (ii) transport is abolished in the presence of AMP-PNP.
Parameters and constants were numerically determined by solving the kinetic models and found to be close to those values that were initially entered into the equations as estimates (supplemental Table S1 ). Models are able to accurately predict all experimental This article has not been copyedited and formatted. The final version may differ from this version. Figure 10 represent modeling data for wild-type (green) and mutant (blue), while filled symbols depict the experimentally determined data points. Clearly, curves generated by the kinetic model show excellent agreement with experimentally determined data points. Physiologically, BSEP is capable of concentrating bile acids in bile canaliculi (Cuperus et al., 2014) . For wild-type protein this causes a concentration gradient from the inside of the vesicle to the outside, which promotes loss of vesicle-accumulated taurocholate back into the medium. In a mutant with facilitative transport characteristics, a gradient between the inside and the outside of the vesicle cannot be generated and thus outward diffusion is not observed. Here a linear behaviour is predicted and experimentally found. In contrast, in wild-type the active transporter generates a concentration gradient, which causes outward diffusion that is dependent on vesicle volume. Here a downward deflection of the curve is observed with increasing osmolarity (from right to left).
DISCUSSION
Homodimeric half transporters, as well as a number of full length transporters have two hydrolysis competent NBSs. In ABCB1 two canonical ATP binding sites find a counterpart in dual substrate binding modes. This duality is rooted in the rotationally symmetric architecture of the protein (Parveen et al., 2011) . However, non-canonical residues are present in the nucleotide binding site 1 of about 40% of human ABC proteins (Procko et al., 2009) . In these transporters symmetry is lost and complexity of the catalytic cycle is reduced. With respect to mechanistic details of ATP binding to a non-canonical NBS1, the following possibilities exist: (i) ATP binds to NBS1 for prolonged periods of time and holds the NBDs together, while NBS2 hydrolyzes ATP in repeated cycles (Basso et al., 2003; Ernst et al., 2008; Gupta et al., 2014; Mishra et al., 2014; Timachi et al., 2017) . (ii) Alternatively, ATP may be released from the non-canonical NBS in un-hydrolyzed form after ATP is hydrolyzed at the canonical NBS. This notion was put forward by Furman et al. for the yeast full length transporter Pdr5 (Furman et al., 2013) .
This article has not been copyedited and formatted. The final version may differ from this version. In the present study we explored inter-domain communication paths in BSEP in order to understand the involvement of the degenerate and the canonical NBS for taurocholate transport. In a first series of experiments the consequences of conferring hydrolysis competency to NBS1 were explored. The ABCB subfamily is the most diverse of all human subfamilies, containing both half-and full-length transporters, as well as members with one or with two hydrolysis competent NBSs. Our mutation strategy was thus guided by sequence differences and similarity within the ABCB subfamily. Accordingly, we replaced non-canonical residues in the Walker B motif, the Q-loop and signature sequence of NBS1 with canonical In a next series of experiments we explored the role of selected residues in conserved motifs, namely the Walker A lysines and D-loop aspartates in both NBSs for ATPase activity and taurocholate transport. The Walker A mutants completely lost transport activity, irrespective of the NBS in which they were mutated. These results are in agreement with earlier data on human TAP1/2, in which mutation of conserved lysine residues in the Walker A motifs similarly abolished transport activity (Azzaria et al., 1989; Lapinski et al., 2001 ). Basal ATPase activity was retained in these mutants indicating that hydrolytic capacity alone is not sufficient to sustain the transport process.
This article has not been copyedited and formatted. The final version may differ from this version. The D-loops have been indicted to be involved in NBD-NBD communication. The eponymous aspartate is conserved in both NBSs of BSEP. In either of the D-loop mutants basal ATPase activity was comparable to that of wild-type. Thus a direct involvement of these residues in ATP hydrolysis seems unlikely. While the D1250A mutant in NBS1 retained its ability to be stimulated by taurocholate, this property was lost by mutating residue D590 in NBS2. In the latter taurocholate transport was abolished, while for analogous mutation in NBS1 (D1250A) transport activity was decreased to 50%. Similar results were reported for two other ABC transporters with one non-canonical NBS, TM287/288 (Hohl et al., 2014) and Pdr5 (Furman et al., 2013 In a final set of experiments we replaced the catalytic glutamate of NBS2 by glutamine. In the ensuing E1244Q mutant we then introduced a glutamate residue into the Walker B motif of NBS1. This double mutant (M584E/E1244Q) consistently showed 15% of wild-type transport activity. Time dependencies showed that steady state levels of uptake were 75 to 80% reduced in the mutant (Figure 9 ), suggesting that this mutant may have lost active and adopted facilitative characteristics. We used a kinetic model to support this notion.
This model comprised a term for loss of taurocholate from the vesicle lumen, which we found to occur after washout of taurocholate and ATP from the incubation medium (data not shown). Though this loss did not in any way compromise interpretation of transport data, it was taken advantage of, in order to corroborate that transport in the mutant was facilitative.
The rational was as follows: Loss of taurocholate from the vesicle would only be observed, when concentrative transport into the vesicle occurs. This would lead to nonlinear curve characteristics. In contrast curves would be expected to be linear for facilitators. This is indeed observed experimentally (Figure 10 ). Because of its strict ATP dependence, the M584E/E1244Q mutant has adopted properties of an ATP-gated facilitator. To the best of our knowledge this has not been shown for any other ABC transporter with one non-canonical This article has not been copyedited and formatted. The final version may differ from this version. NBS. An earlier report by Robert Tampé's group engineered TAP1/2 to act as a facilitator (Grossmann et al., 2014) . However, in this case the change in properties was brought about by mutating the aspartate in the D-loop of TAP1; the transporter differs from the BSEP mutant in that ADP and AMP-PNP can replace ATP in function.
In Figure 11 , we propose a model for the inter-domain communication of BSEP based on data from this study. Transport is a measure of the ability of NBS2 (canonical) to communicate conformational changes to the taurocholate binding site. On the other hand, stimulation of basal ATPase activity by taurocholate reflects the ability of the taurocholate binding site to signal to NBS2 that substrate has been bound. Both these inter-domain communication paths are present in wild-type protein ( Figure 11A ), but lost in the E1244Q
( Figure 11B ), the K1119M and the D590A mutant ( Figure 11C ). In the M584E/E1244Q mutant (D) taurocholate is transported in facilitative manner. Here NBS2 is not able to hydrolyse ATP. However, we propose that ATP is able to dissociate from its binding site in un-hydrolyzed form, when ATP is hydrolysed in NBS1. This ensures that the protein can complete its catalytic cycle to return to a substrate binding competent state. Because of the inability of NBS2 to hydrolyze ATP, substrate affinity would remain higher for the facilitator in the outward facing conformation and thus result in the loss of active transport characteristics.
With respect to a reduction of the number of hydrolysis competent nucleotide binding sites from two to one in about half of human ABC transporters (including BSEP and the entire ABCC subfamily), the following can be stated: (i) development of full transporters, from homodimeric half transporters by gene duplication represented a prerequisite for evolution of these asymmetric proteins (Chen et al., 1986; Kerr, 2002; Ueda et al., 1989) . A second path to ABC proteins with only one non-canonical NBS was the evolution of heterodimeric half transporters. This is infrequently observed and only seen for TAP1/2 and ABCG5/G8 (ii) A selective advantage may have arisen from the ensuing change in substrate specificity, be it in either broadening it in full transporters with two hydrolysis competent NBSs or narrowing it in those that only contain one. Any proof of co-evolution of residues in the TMDs and causally related changes in NBS1 (evolutionary coupling, (Hopf et al., 2017) ) should be able have resulted in restricting substrate specificity to negatively charged bile salts, while excluding compounds of alternative chemistry. Though entirely conjectural at present, the large number of small molecule drugs, which are capable of direct interaction with (and inhibition of) BSEP, may be a reflection of the presence of an evolutionarily retained former substrate binding site, which has lost coupling to a canonical nucleotide binding site.
Conclusion
We engineered BSEP in order to shed light on the molecular mechanism of taurocholate transport. This allows us to present a model for taurocholate transport with respect to its coupling to the energy generating step. Our data are expected to form a basis for exploration of the taurocholate binding site and an understanding of the interaction between the transporter and drugs. It is also expected to promote an understanding of the functional biology of other members of the human ABC protein family which harbour one non-canonical nucleotide binding site. Horizontal bars indicate mean values. In order to calculate statistical differences between the groups, averages of individual experiment (n=3) were subjected to one-way ANOVA, followed by Tukey's post hoc test in order to compare more than one group with wild-type.
Statistical significance levels are indicated by asterisks (***, p < 0.001). ns, no statistical significance. Thus n was three for all mutants, but 13 for wild-type. Mean values ± standard deviation are shown. Statistically significant differences between basal and taurocholate stimulated ATPase activity was determined by two-way ANOVA followed by Bonferroni post hoc analysis. Statistical significance levels are indicated by asterisks (***, p < 0.001; *, p < 0.05).
ns, no statistical significance. 
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